Rapid-response vaccines - does DNA offer a solution?

Autoria(s): Forde, Gareth M.
Data(s)

2005
Resumo

In responding to future influenza pandemics and other infectious agents, plasmid DNA overcomes many of the limitations of conventional vaccine production approaches.
Identificador

http://eprints.qut.edu.au/81576/
Publicador

Nature Publishing Group
Relação

DOI:10.1038/nbt0905-1059

Forde, Gareth M. (2005) Rapid-response vaccines - does DNA offer a solution? Nature Biotechnology, 23(9), pp. 1059-1062.
Direitos

Copyright 2005 Nature Publishing Group
Fonte

School of Chemistry, Physics & Mechanical Engineering; Science & Engineering Faculty
Palavras-Chave #DNA #Infectious agents #Influenza pandemics #Vaccines #antivirus agent #atorvastatin #DNA vaccine #influenza vaccine #plasmid DNA #recombinant vaccine #smallpox vaccine #autoimmune disease #avian influenza #biotechnology #clinical trial #cost benefit analysis #cost control #disease transmission #drug cost #drug delivery system #drug manufacture #drug packaging #drug purification #drug quality #food and drug administration #genetic engineering #human #immunization #immunogenicity #infection prevention #nonhuman #priority journal #quality control #review #severe acute respiratory syndrome #vaccination #vaccine production #virus strain #West Nile flavivirus #Animals #Disease Outbreaks #Humans #Influenza Vaccines #Influenza #Human #Mice #Plasmids #Time Factors #Vaccines #DNA #Virology #World Health #Aves #Variola virus #West Nile virus
Tipo

Journal Article
Acesso ao item digital